Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
Open Access
- 1 January 2013
- journal article
- research article
- Published by XMLink in Yonsei Medical Journal
- Vol. 54 (5) , 1178-1185
Abstract
Cha J, et al. Yonsei Med J. 2013 Sep;54(5):1178-1185. https://doi.org/10.3349/ymj.2013.54.5.1178Keywords
Funding Information
- Ministry of Health and Welfare (0620390)
This publication has 33 references indexed in Scilit:
- Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinomaCancer, 2011
- Sorafenib improves the survival of patients with advanced hepatocellular carcinoma: a meta-analysis of randomized trialsAnti-Cancer Drugs, 2010
- Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with SorafenibThe Oncologist, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinomaBritish Journal of Radiology, 2007
- Angiogenesis and hepatocellular carcinomaJournal of Hepatology, 2004
- Radioresponse of Hepatocellular Carcinoma-Treatment of Lymph Node MetastasisCancer Research and Treatment, 2004
- Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)Journal of Gastroenterology, 2003